• Health

A study in 30 Spanish hospitals shows that a two-drug HIV therapy remains more effective than a three-drug one.

Dolutegravir/lamivudine demonstrated non-inferiority to bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) in HIV-infected adults with suppressed viral load. SEIMC-GeSIDA Foundation and ViiV Healthcare…